Convenience: Online consultations and discreet delivery
Elsevier, Gofron, Krzysztof Ksawery, et al
Clinical trials found that people who took semaglutide lost an average of 10% more body weight than those who were given a placebo over one year of treatment
Abdominal distension, abdominal discomfort, vomiting, abdominal pain upper, and flatulence have higher reporting ranks in males, while off-label use, injection site rash, injection site injury, injection site urticaria, and product administered at an inappropriate site have higher reporting ranks in females
Funding This work was supported by grants from National Natural Science Foundation of China (81902668), Yubei District Science and Technology Commission of Chongqing (2020-36) to PY, and National Natural Science Foundation of China Grants (31771545, 91749120 and 31821002) to WY